Chronic systemic complex I inhibition induces a hypokinetic multisystem degeneration in rats
Open accessThe DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Abstract
In Parkinson's disease, nigral dopaminergic neurones degenerate, whereas post‐synaptic striatal target neurones are spared. In some atypical parkinsonian syndromes, both nigral and striatal neurones degenerate. Reduced activity of complex I of the mitochondrial respiratory chain has been implicated in both conditions, but it remains unclear if this affects the whole organism or only the degenerating brain structures. We therefore investigated the differential vulnerability of various brain structures to generalized complex I inhibition. Male Lewis rats infused with rotenone, a lipophilic complex I inhibitor [2.5 mg/kg/day intraveneously (i.v.) for 28 days], were compared with vehicle‐infused controls. They showed reduced locomotor activity and loss of striatal dopaminergic fibres (54%), nigral dopaminergic neurones (28.5%), striatal serotoninergic fibres (34%), striatal DARPP‐32‐positive projection neurones (26.5%), striatal cholinergic interneurones (22.1%), cholinergic neurones in the pedunculopontine tegmental nucleus (23.7%) and noradrenergic neurones in the locus ceruleus (26.4%). Silver impregnation revealed pronounced degeneration in basal ganglia and brain stem nuclei, whereas the hippocampus, cerebellum and cerebral cortex were less affected. These data suggest that a generalized mitochondrial failure may be implicated in atypical parkinsonian syndromes but do not support the hypothesis that a generalized complex I inhibition results in the rather selective nigral lesion observed in Parkinson's disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Chronic systemic pesticide exposure reproduces features of Parkinson's disease
Betarbet, R., Sherer, T. B., MacKenzie, G., Garcia-Osuna, M., Panov, A. V., & Greenamyre, J. T. (2000) · Nature Neuroscience · doi:10.1038/81834 · Cited by 3,683
STEELE, J. C. (1964) · Archives of Neurology · doi:10.1001/archneur.1964.00460160003001 · Cited by 1,924
Ehringer, H., & Hornykiewicz, O. (1960) · Klinische Wochenschrift · doi:10.1007/bf01485901 · Cited by 1,867
MITOCHONDRIAL COMPLEX I DEFICIENCY IN PARKINSON'S DISEASE
Schapira, A. H. V., Cooper, J. M., Dexter, D., Jenner, P., Clark, J. B., & Marsden, C. D. (1989) · The Lancet · doi:10.1016/s0140-6736(89)92366-0 · Cited by 1,756
Javitch, J. A., D'Amato, R. J., Strittmatter, S. M., & Snyder, S. H. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.7.2173 · Cited by 1,263
Nicklas, W. J., Vyas, I., & Heikkila, R. E. (1985) · Life Sciences · doi:10.1016/0024-3205(85)90146-8 · Cited by 1,262
Abnormalities of the electron transport chain in idiopathic parkinson's disease
Parker, W. D., Boyson, S. J., & Parks, J. K. (1989) · Annals of Neurology · doi:10.1002/ana.410260606 · Cited by 1,063
Beal, M., Brouillet, E., Jenkins, B., Ferrante, R., Kowall, N., Miller, J., Storey, E., Srivastava, R., Rosen, B., & Hyman, B. (1993) · The Journal of Neuroscience · doi:10.1523/jneurosci.13-10-04181.1993 · Cited by 1,027
Annonaceous Acetogenins: Recent Progress
Alali, F. Q., Liu, X.-X., & McLaughlin, J. L. (1999) · Journal of Natural Products · doi:10.1021/np980406d · Cited by 818
CENTRAL CERVICAL CORD SYNDROME AFTER HEADING A FOOTBALL
Scoppetta, C., & Vaccario, M. (1978) · The Lancet · doi:10.1016/s0140-6736(78)92517-5 · Cited by 753
Schapira, A. H. V., Mann, V. M., Cooper, J. M., Dexter, D., Daniel, S. E., Jenner, P., Clark, J. B., & Marsden, C. D. (1990) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1990.tb05809.x · Cited by 673
Age-dependent vulnerability of the striatum to the mitochondrial toxin 3-nitropropionic acid
Brouillet, E., Jenkins, B. G., Hyman, B. T., Ferrante, R. J., Kowall, N. W., Srivastava, R., Roy, D. S., Rosen, B. R., & Beal, M. F. (1993) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1993.tb05859.x · Cited by 367 · cited 3×
“…animals, the nigrostriatal dopaminergic inputs have been reported to be relatively intact after 3-NP intoxication (Beal et al. 1993; Brouillet et al. 1993; Wüllner et al. 1994), although extrastriatal lesions have been described in the pallidum, the hippocampus and the substantia…”
BackgroundRichards, O. W., & Windholz, M. (1978) · Transactions of the American Microscopical Society · doi:10.2307/3225642 · Cited by 363
Jellinger, K. A. (1999) · Journal of Neural Transmission. Supplementa · doi:10.1007/978-3-7091-6360-3_1 · Cited by 347
BRAIN, SKELETAL MUSCLE AND PLATELET HOMOGENATE MITOCHONDRIAL FUNCTION IN PARKINSON'S DISEASE
MANN, V. M., COOPER, J. M., KRIGE, D., DANIEL, S. E., SCHAPIRA, A. H. V., & MARSDEN, C. D. (1992) · Brain · doi:10.1093/brain/115.2.333 · Cited by 346
Mitochondrial dysfunction and oxidative stress in aging and neurodegenerative disease
Albers, D. S., & Flint Beal, M. (2000) · Advances in Dementia Research · doi:10.1007/978-3-7091-6781-6_16 · Cited by 297
STRIATONIGRAL DEGENERATION: A CLINICOPATHOLOGICAL STUDY
FEARNLEY, J. M., & LEES, A. J. (1990) · Brain · doi:10.1093/brain/113.6.1823 · Cited by 296
Inhibition of mitochondrial complexes I and IV by 6-hydroxydopamine
Glinka, Y. Y., & Youdim, M. B. H. (1995) · European Journal of Pharmacology: Environmental Toxicology and Pharmacology · doi:10.1016/0926-6917(95)90040-3 · Cited by 283
Daniel, S. E., de Bruin, V. M. S., & Lees, A. J. (1995) · Brain · doi:10.1093/brain/118.3.759 · Cited by 274
The Merck Index. An Encyclopedia of Chemicals and Drugs.
(1968) · Annals of Internal Medicine · doi:10.7326/0003-4819-69-6-1342_2 · Cited by 260
Caparros-Lefebvre, D., & Elbaz, A. (1999) · The Lancet · doi:10.1016/s0140-6736(98)10166-6 · Cited by 255
MITOCHONDRIAL FUNCTION IN PARKINSON'S DISEASE
Bindoff, L. A., Birch-Machin, M., Cartlidge, N. E. F., Parker, W. D., & Turnbull, D. M. (1989) · The Lancet · doi:10.1016/s0140-6736(89)90291-2 · Cited by 242
Hamilton, B. F., & Gould, D. H. (1987) · Acta Neuropathologica · doi:10.1007/bf00691103 · Cited by 230
Pathology of Parkinson's Disease
(2006) · Understanding Parkinson's Disease · doi:10.5040/9798216029700.0007 · Cited by 206
Ferrante, R. J., Schulz, J. B., Kowall, N. W., & Beal, M. F. (1997) · Brain Research · doi:10.1016/s0006-8993(97)00008-5 · Cited by 203
Guadeloupean parkinsonism: a cluster of progressive supranuclear palsy‐like tauopathy
Caparros‐Lefebvre, D., Sergeant, N., Lees, A., Camuzat, A., Daniel, S., Lannuzel, A., Brice, A., Tolosa, E., Delacourte, A., & Duyckaerts, C. (2002) · Brain · doi:10.1093/brain/awf086 · Cited by 170
Guyot, M.-C., Hantraye, P., Dolan, R., Palfi, S., Maziére, M., & Brouillet, E. (1997) · Neuroscience · doi:10.1016/s0306-4522(96)00602-1 · Cited by 158
Cryopreservation of primary neurons for tissue culture
Kawamoto, J. C., & Barrett, J. N. (1986) · Brain Research · doi:10.1016/0006-8993(86)91222-9 · Cited by 157
3‐Nitropropionic Acid Toxicity in the Striatum
Wüllner, U., Young, A. B., Penney, J. B., & Beal, M. F. (1994) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1994.63051772.x · Cited by 145
Simon, D. K., Pulst, S. M., Sutton, J. P., Browne, S. E., Beal, M. F., & Johns, D. R. (1999) · Neurology · doi:10.1212/wnl.53.8.1787 · Cited by 141
Acute and reversible parkinsonism due to organophosphate pesticide intoxication
Bhatt, M. H., Elias, M. A., & Mankodi, A. K. (1999) · Neurology · doi:10.1212/wnl.52.7.1467 · Cited by 131
Dégénérescences nigro-striées et cerebello-nigro-striées; pp. 219–232
Adams, R. D., van Bogaert, L., & van der Eecken, H. (2008) · Psychiatria et Neurologia · doi:10.1159/000131165 · Cited by 104
Respiratory chain and mitochondrial DNA in muscle and brain in Parkinson's disease patients
DiDonato, S., Zeviani, M., Giovannini, P., Savarese, N., Rimoldi, M., Mariotti, C., Girotti, F., & Caraceni, T. (1993) · Neurology · doi:10.1212/wnl.43.11.2262 · Cited by 98
Swerdlow, R. H., Golbe, L. I., Parks, J. K., Cassarino, D. S., Binder, D. R., Grawey, A. E., Litvan, I., Bennett, J. P., Wooten, G. F., & Parker, W. D. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0751681.x · Cited by 95
Michel, P. P., & Agid, Y. (1996) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1996.67041633.x · Cited by 87
Self-citationFurther Evidence for Mitochondrial Dysfunction in Progressive Supranuclear Palsy
Albers, D. S., Swerdlow, R. H., Manfredi, G., Gajewski, C. D., Yang, L., Parker, W. D., & Beal, M. F. (2001) · Experimental Neurology · doi:10.1006/exnr.2000.7607 · Cited by 75
Borlongan, C. V., Koutouzis, T. K., Freeman, T. B., Hauser, R. A., Cahill, D. W., & Sanberg, P. R. (1997) · Brain Research Protocols · doi:10.1016/s1385-299x(96)00037-2 · Cited by 70
New insights into progressive supranuclear palsy
Albers, D. S., & Augood, S. J. (2001) · Trends in Neurosciences · doi:10.1016/s0166-2236(00)01794-x · Cited by 69
Albin, R. L. (2000) · Neurologic Clinics · doi:10.1016/s0733-8619(05)70217-6 · Cited by 64
Nondopaminergic neurons in Parkinson's disease.
Hirsch, É. C., Orieux, G., Muriel, M.-P., François, C., & Féger, J. (2003) · PubMed · Cited by 40
Self-citationWaldvogel (1999) · doi:10.1002/1531-8249(199907)46:1
Cited by
Dauer, W., & Przedborski, S. (2003) · Neuron · doi:10.1016/s0896-6273(03)00568-3 · Cited by 5,469
Mechanism of Toxicity in Rotenone Models of Parkinson's Disease
Sherer, T. B., Betarbet, R., Testa, C. M., Seo, B. B., Richardson, J. R., Kim, J. H., Miller, G. W., Yagi, T., Matsuno-Yagi, A., & Greenamyre, J. T. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-34-10756.2003 · Cited by 1,072
Mitochondria in the aetiology and pathogenesis of Parkinson's disease
Schapira, A. H. (2008) · The Lancet Neurology · doi:10.1016/s1474-4422(07)70327-7 · Cited by 883
Duty, S., & Jenner, P. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01426.x · Cited by 753
Toxin-induced models of Parkinson’s disease
Bové, J., Prou, D., Perier, C., & Przedborski, S. (2005) · NeuroRX · doi:10.1602/neurorx.2.3.484 · Cited by 739
“striatum were all found significantly reduced by the infusion of rotenone in rats.(110,111) Unexpectedly, even at doses of rotenone that did not damage the nigrostriatal”
BackgroundResultInfluential
Metadata
- Authors
- Höglinger, G. U., Féger, J., Prigent, A., Michel, P. P., Parain, K., Champy, P., Ruberg, M., Oertel, W. H., & Hirsch, E. C.
- Venue
- Journal of Neurochemistry
- Publisher
- Wiley
- Published
- 2003-01-13
- Volume
- 84
- Issue
- 3
- Pages
- 491-502
- ISSN
- 0022-3042 (ISSN-L)
- 1471-4159
- OpenAlex
- W1584829548
- Cited by
- 331
- References
- 41
- FWCI
- 18.22
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.